Coordination and planning of clinical research on a national and global level
We describe the current global approaches to con- ducting clinical trials and identifies how new methodology and greater collaboration could expedite the discovery of new treatments.
Volume 113, Issue 6, Pages 1100–1106
Adam J. Devall, Ph.D.l, Henk Jan Out, Ph.D., Ben Willem J. Mol, Ph.D., James M.N. Duffy, D.Phil., Barbara Collura, M.A., Silke Dyer, Ph.D.
In reproductive medicine, the needs and desires of infertility patients drive future research, with the most important outcome being live birth of a baby. Large, multicenter, randomized clinical trials are considered the best research tool to evaluate the effectiveness of medical interventions, but they can often take a long time to find definitive answers. Advances in individual participant data (IPD) and network meta-analysis have enabled research questions to be answered more quickly, but better planning could streamline this process further. To harmonize research findings that are taking place globally in this way, it is crucial that the same outcomes are collected in clinical trials conducted in reproductive medicine. Furthermore, the conduct of clinical trials often requires collaboration on an international scale; however, individual countries have their own processes for research prioritization and delivery. We describe the perspective of high- and low-resourced settings and industry as well as the mechanisms of prioritization and coordination that are in place in different settings. In addition, we discuss the importance of the patient perspective, which can help shape the research question, clinical trial design, and the logistical operations of trial delivery. The need for increased global collaboration and coalitions within and between stakeholders is evident for the research community to accelerate advances and maximize benefits in reproductive medicine.